Connection

Jean-Charles Soria to Antimetabolites, Antineoplastic

Back to Details
This is a "connection" page, showing publications Jean-Charles Soria has written about Antimetabolites, Antineoplastic.
Jean-Charles Soria
Connection Strength
0.199
Antimetabolites, Antineoplastic
  1. Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors. Cancer Chemother Pharmacol. 2017 Jun; 79(6):1257-1265.
    View in: PubMed
    Score: 0.159
  2. Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study. Eur J Cancer. 2017 09; 83:194-202.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.